These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
544 related items for PubMed ID: 7741542
21. Efficacy and safety of calcipotriol (MC 903) ointment in psoriasis vulgaris. A randomized, double-blind, right/left comparative, vehicle-controlled study. Dubertret L, Wallach D, Souteyrand P, Perussel M, Kalis B, Meynadier J, Chevrant-Breton J, Beylot C, Bazex JA, Jurgensen HJ. J Am Acad Dermatol; 1992 Dec; 27(6 Pt 1):983-8. PubMed ID: 1479106 [Abstract] [Full Text] [Related]
22. Calcipotriol. A new topical antipsoriatic. Kragballe K, Iversen L. Dermatol Clin; 1993 Jan; 11(1):137-41. PubMed ID: 8435908 [Abstract] [Full Text] [Related]
23. Comparative effects of calcipotriol ointment (50 micrograms/g) and 5% coal tar/2% allantoin/0.5% hydrocortisone cream in treating plaque psoriasis. Pinheiro N. Br J Clin Pract; 1997 Jan; 51(1):16-9. PubMed ID: 9158266 [Abstract] [Full Text] [Related]
24. Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study. Fleming C, Ganslandt C, Guenther L, Johannesson A, Buckley C, Simon JC, Stegmann H, Vestergaard Tingleff L. Eur J Dermatol; 2010 Jan; 20(4):465-71. PubMed ID: 20413372 [Abstract] [Full Text] [Related]
25. Management of psoriasis with calcipotriol used as monotherapy. Ramsay CA. J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S53-4. PubMed ID: 9344185 [Abstract] [Full Text] [Related]
26. Topical calcipotriol (MC 903) for psoriasis: a clinical study. Mozzanica N, Cattaneo A, Schmitt E, Legori A, Finzi AF. Acta Derm Venereol Suppl (Stockh); 1994 Sep; 186():169-70. PubMed ID: 8073826 [Abstract] [Full Text] [Related]
27. Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo. Goldinger SM, Dummer R, Schmid P, Burg G, Seifert B, Läuchli S. J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):504-8. PubMed ID: 17373978 [Abstract] [Full Text] [Related]
28. Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial. Liao YH, Chiu HC, Tseng YS, Tsai TF. Br J Dermatol; 2007 Nov; 157(5):1005-12. PubMed ID: 17935517 [Abstract] [Full Text] [Related]
29. Calcipotriene ointment applied once a day for psoriasis: a double-blind, multicenter, placebo-controlled study. Pariser DM, Pariser RJ, Breneman D, Lebwohl M, Kalb R, Moore J, Moss H, Parker C, Fiedler V. Arch Dermatol; 1996 Dec; 132(12):1527. PubMed ID: 8961897 [No Abstract] [Full Text] [Related]
30. Efficacy and safety of topical calcitriol (1,25-dihydroxyvitamin d3) for the treatment of psoriasis. Pèrez A, Chen TC, Turner A, Raab R, Bhawan J, Poche P, Holick MF. Br J Dermatol; 1996 Feb; 134(2):238-46. PubMed ID: 8746336 [Abstract] [Full Text] [Related]
31. Calcipotriol in the treatment of childhood vitiligo. Gargoom AM, Duweb GA, Elzorghany AH, Benghazil M, Bugrein OO. Int J Clin Pharmacol Res; 2004 Feb; 24(1):11-4. PubMed ID: 15575172 [Abstract] [Full Text] [Related]
32. Comparison of tazarotene 0.1% gel plus petrolatum once daily versus calcipotriol 0.005% ointment twice daily in the treatment of plaque psoriasis. Tzung TY, Wu JC, Hsu NJ, Chen YH, Ger LP. Acta Derm Venereol; 2005 Feb; 85(3):236-9. PubMed ID: 16040409 [Abstract] [Full Text] [Related]
33. Flow-cytometric investigation of epidermal cell characteristics in monogenic disorders of keratinization and their modulation by topical calcipotriol treatment. Lucker GP, Steijen PM, Suykerbuyk EJ, Kragballe K, Brandrup F, van de Kerkhof PC. Acta Derm Venereol; 1996 Mar; 76(2):97-101. PubMed ID: 8740259 [Abstract] [Full Text] [Related]
34. Efficacy of topical 10% urea-based lotion in patients with ichthyosis vulgaris: a two-center, randomized, controlled, single-blind, right-vs.-left study in comparison with standard glycerol-based emollient cream. Tadini G, Giustini S, Milani M. Curr Med Res Opin; 2011 Dec; 27(12):2279-84. PubMed ID: 22007909 [Abstract] [Full Text] [Related]
35. Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 microg g(-1) ointment and calcipotriol 50 microg g(-1) ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas. Ortonne JP, Humbert P, Nicolas JF, Tsankov N, Tonev SD, Janin A, Czernielewski J, Lahfa M, Dubertret L. Br J Dermatol; 2003 Feb; 148(2):326-33. PubMed ID: 12588387 [Abstract] [Full Text] [Related]
36. Can topical calcipotriol be a treatment alternative in actinic keratoses? A preliminary report. Seckin D, Cerman AA, Yildiz A, Ergun T. J Drugs Dermatol; 2009 May; 8(5):451-4. PubMed ID: 19537367 [Abstract] [Full Text] [Related]
37. [Treatment options in monogenic disorders of keratinization]. van de Kerkhof PC. J Dtsch Dermatol Ges; 2003 Oct; 1(10):763-4. PubMed ID: 16281811 [No Abstract] [Full Text] [Related]
38. A double-blind, randomized quantitative comparison of calcitriol ointment and calcipotriol ointment on epidermal cell populations, proliferation and differentiation. Körver JE, Vissers WH, van Rens DW, Pasch MC, van Erp PE, Boezeman JB, van De Kerkhof PC. Br J Dermatol; 2007 Jan; 156(1):130-7. PubMed ID: 17199579 [Abstract] [Full Text] [Related]
39. The effect of combined calcipotriol and betamethasone dipropionate ointment in the treatment of vitiligo: an open, uncontrolled trial. Xing C, Xu A. J Drugs Dermatol; 2012 Oct; 11(10):e52-4. PubMed ID: 23135000 [Abstract] [Full Text] [Related]
40. Topical calcipotriol in the treatment of intertriginous psoriasis. Kienbaum S, Lehmann P, Ruzicka T. Br J Dermatol; 1996 Oct; 135(4):647-50. PubMed ID: 8915166 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]